BIOARCTIC AB (BRCTF:OTCMKTS)
$36.9248 2.8748 (8.4429%)
Analysed BIOARCTIC AB (BRCTF:OTCMKTS) News Sources
BLA for subcutaneous formulation of Leqembi® designated for Priority Review in China
09-02-2026
yahoo.com
Invitation to presentation of BioArctic's fourth quarter report for October - December 2025 on February 18 at 9.30 a.m. CET
11-02-2026
yahoo.com
Invitation to presentation of BioArctic's second quarter report for April - June 2026 on August 26 at 9:30 a.m. CEST
19-08-2026
yahoo.com
BioArctic and Mesenkia enter oncology research collaboration
19-08-2026
yahoo.com
Leqembi Iqlik® for initiation treatment launched in the US
24-08-2026
yahoo.com
BioArctic: Interim Report for the period April - June 2026
26-08-2026
yahoo.com
Eli Lilly (LLY) Adds Alzheimer’s Research Deal As Obesity Cost Data Builds
26-08-2026
yahoo.com
Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
31-08-2026
yahoo.com
Leqembi® Pen subcutaneous formulation approved in Japan
16-09-2026
yahoo.com
BioArctic AB (BRCTF) (Q2 2026) Earnings Call Highlights: FDA Approval of Leqembi Autoinjector ...
26-08-2026
yahoo.com
What is the current price of BIOARCTIC AB (BRCTF:OTCMKTS)?
The current price of BIOARCTIC AB (BRCTF:OTCMKTS) is $36.9248.
BIOARCTIC AB (BRCTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOARCTIC AB (BRCTF:OTCMKTS) since the previous trading day is $2.8748.
BIOARCTIC AB (BRCTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOARCTIC AB (BRCTF:OTCMKTS) since the previous trading day is 8.4429%.
What is the most recent average sentiment score for BIOARCTIC AB (BRCTF:OTCMKTS)?
The most recent average sentiment score for BIOARCTIC AB (BRCTF:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for BIOARCTIC AB (BRCTF:OTCMKTS)?
The most recent sentiment for BIOARCTIC AB (BRCTF:OTCMKTS) is .
SEC-8K** Filing Available For BIOARCTIC AB (BRCTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.